Overview

A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin

Status:
Completed
Trial end date:
2017-06-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the potential for a drug interaction between GDC-0853 and midazolam, itraconazole, rosuvastatin, and simvastatin.
Phase:
Phase 1
Details
Lead Sponsor:
Genentech, Inc.
Treatments:
Hydroxyitraconazole
Itraconazole
Midazolam
Rosuvastatin Calcium
Simvastatin